Research graph
References from Attenuating payload potency expands the therapeutic window of immunotoxins. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1186/s40364-024-00565-1
10.1186/s40364-024-00565-1 · External reference
10.1038/nrc3559
10.1038/nrc3559 · External reference
10.1186/s13046-022-02515-x
10.1186/s13046-022-02515-x · External reference
10.1517/14728222.2011.648617
10.1517/14728222.2011.648617 · External reference
10.1038/s41571-019-0268-3
10.1038/s41571-019-0268-3 · External reference
10.1038/nrc903
10.1038/nrc903 · External reference
10.1111/j.1742-4658.2011.08182.x
10.1111/j.1742-4658.2011.08182.x · External reference
10.3389/fmicb.2019.02340
10.3389/fmicb.2019.02340 · External reference
Optimizing Denileukin Diftitox (Ontak®) Therapy
10.2217/14796694.4.4.457 · 2008 · External reference
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
10.1182/bloodadvances.2019000173 · 2020 · External reference
10.1007/s40265-018-1000-9
10.1007/s40265-018-1000-9 · External reference
10.1634/theoncologist.2014-0358
10.1634/theoncologist.2014-0358 · External reference
Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective
10.1093/abt/tbac014 · 2022 · External reference
10.3390/ijms232415820
10.3390/ijms232415820 · External reference
10.1016/j.ccell.2022.09.016
10.1016/j.ccell.2022.09.016 · External reference
10.1126/sciadv.adk1894
10.1126/sciadv.adk1894 · External reference
10.3390/cancers15030713
10.3390/cancers15030713 · External reference
10.1016/0092-8674(78)90099-5
10.1016/0092-8674(78)90099-5 · External reference
10.1016/s0041-0101(01)00165-9
10.1016/s0041-0101(01)00165-9 · External reference
10.1128/br.39.1.54-85.1975
10.1128/br.39.1.54-85.1975 · External reference
10.1007/978-1-4419-8632-0_5
10.1007/978-1-4419-8632-0_5 · External reference
10.1021/bi00489a021
10.1021/bi00489a021 · External reference
Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli
10.1007/s12033-017-0001-3 · 2017 · External reference
An enhanced intracellular delivery platform based on a distant diphtheria toxin homolog that evades pre-existing antitoxin antibodies
10.1038/s44321-024-00116-z · 2024 · External reference
10.1158/0008-5472.can-15-0159
10.1158/0008-5472.can-15-0159 · External reference
10.1038/s41587-023-01840-6
10.1038/s41587-023-01840-6 · External reference
